Enabling liver transplantation during the COVID-19 era: More than screening donors and recipients for SARS-CoV-2.

The consequences of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the early postoperative course after liver transplantation (LT) are still not fully known. While data is scarce, it indicates that the incidence of early post-transplant coronavirus disease-19 (COVID-19) may reach up to 38% (). Some centers have developed strategies for performing LT during the pandemic and, after implementing a multimodal stepwise approach, these facilities could minimize the risk of recipient SARS-CoV-2 infection (,). These measures may be summarized as [...]